United States Poliomyelitis Vaccine Market Report & Forecast 2021-2027

United States Poliomyelitis Vaccine Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Poliomyelitis Vaccine Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Poliomyelitis Vaccine Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Poliomyelitis Vaccine Overall Market Size
2.1 United States Poliomyelitis Vaccine Market Size: 2021 VS 2027
2.2 United States Poliomyelitis Vaccine Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Poliomyelitis Vaccine Sales: 2016-2027
3 Company Landscape
3.1 Top Poliomyelitis Vaccine Players in United States Market
3.2 Top United States Poliomyelitis Vaccine Companies Ranked by Revenue
3.3 United States Poliomyelitis Vaccine Revenue by Companies
3.4 United States Poliomyelitis Vaccine Sales by Companies
3.5 United States Poliomyelitis Vaccine Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Poliomyelitis Vaccine Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Poliomyelitis Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Poliomyelitis Vaccine Players in United States Market
3.8.1 List of Tier 1 Poliomyelitis Vaccine Companies in United States
3.8.2 List of Tier 2 and Tier 3 Poliomyelitis Vaccine Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Poliomyelitis Vaccine Market Size Markets, 2021 & 2027
4.1.2 Poliomyelitis Vaccine ?
4.1.3 Poliomyelitis Vaccine ?
4.1.4 Poliomyelitis Vaccine ?
4.1.5 Oral Poliomyelitis Vaccine
4.2 By Type - United States Poliomyelitis Vaccine Revenue & Forecasts
4.2.1 By Type - United States Poliomyelitis Vaccine Revenue, 2016-2021
4.2.2 By Type - United States Poliomyelitis Vaccine Revenue, 2022-2027
4.2.3 By Type - United States Poliomyelitis Vaccine Revenue Market Share, 2016-2027
4.3 By Type - United States Poliomyelitis Vaccine Sales & Forecasts
4.3.1 By Type - United States Poliomyelitis Vaccine Sales, 2016-2021
4.3.2 By Type - United States Poliomyelitis Vaccine Sales, 2022-2027
4.3.3 By Type - United States Poliomyelitis Vaccine Sales Market Share, 2016-2027
4.4 By Type - United States Poliomyelitis Vaccine Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Poliomyelitis Vaccine Market Size, 2021 & 2027
5.1.2 VAPP
5.1.3 VDPV
5.2 By Application - United States Poliomyelitis Vaccine Revenue & Forecasts
5.2.1 By Application - United States Poliomyelitis Vaccine Revenue, 2016-2021
5.2.2 By Application - United States Poliomyelitis Vaccine Revenue, 2022-2027
5.2.3 By Application - United States Poliomyelitis Vaccine Revenue Market Share, 2016-2027
5.3 By Application - United States Poliomyelitis Vaccine Sales & Forecasts
5.3.1 By Application - United States Poliomyelitis Vaccine Sales, 2016-2021
5.3.2 By Application - United States Poliomyelitis Vaccine Sales, 2022-2027
5.3.3 By Application - United States Poliomyelitis Vaccine Sales Market Share, 2016-2027
5.4 By Application - United States Poliomyelitis Vaccine Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Overview
6.1.3 GSK Poliomyelitis Vaccine Sales and Revenue in United States Market (2016-2021)
6.1.4 GSK Poliomyelitis Vaccine Product Description
6.1.5 GSK Recent Developments
6.2 Sanofi-Pasteur
6.2.1 Sanofi-Pasteur Corporation Information
6.2.2 Sanofi-Pasteur Overview
6.2.3 Sanofi-Pasteur Poliomyelitis Vaccine Sales and Revenue in United States Market (2016-2021)
6.2.4 Sanofi-Pasteur Poliomyelitis Vaccine Product Description
6.2.5 Sanofi-Pasteur Recent Developments
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Overview
6.3.3 Merck Poliomyelitis Vaccine Sales and Revenue in United States Market (2016-2021)
6.3.4 Merck Poliomyelitis Vaccine Product Description
6.3.5 Merck Recent Developments
6.4 Crucell
6.4.1 Crucell Corporation Information
6.4.2 Crucell Overview
6.4.3 Crucell Poliomyelitis Vaccine Sales and Revenue in United States Market (2016-2021)
6.4.4 Crucell Poliomyelitis Vaccine Product Description
6.4.5 Crucell Recent Developments
6.5 China National Biotech Group
6.5.1 China National Biotech Group Corporation Information
6.5.2 China National Biotech Group Overview
6.5.3 China National Biotech Group Poliomyelitis Vaccine Sales and Revenue in United States Market (2016-2021)
6.5.4 China National Biotech Group Poliomyelitis Vaccine Product Description
6.5.5 China National Biotech Group Recent Developments
6.6 Eli Lilly
6.6.1 Eli Lilly Corporation Information
6.6.2 Eli Lilly Overview
6.6.3 Eli Lilly Poliomyelitis Vaccine Sales and Revenue in United States Market (2016-2021)
6.6.4 Eli Lilly Poliomyelitis Vaccine Product Description
6.6.5 Eli Lilly Recent Developments
7 United States Poliomyelitis Vaccine Production Capacity, Analysis
7.1 United States Poliomyelitis Vaccine Production Capacity, 2016-2027
7.2 Poliomyelitis Vaccine Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Poliomyelitis Vaccine Supply Chain Analysis
9.1 Poliomyelitis Vaccine Industry Value Chain
9.2 Poliomyelitis Vaccine Upstream Market
9.3 Poliomyelitis Vaccine Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Poliomyelitis Vaccine Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Poliomyelitis Vaccine in United States Market
Table 2. Top Poliomyelitis Vaccine Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Poliomyelitis Vaccine Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Poliomyelitis Vaccine Revenue Share by Companies, 2016-2021
Table 5. United States Poliomyelitis Vaccine Sales by Companies, (K Units), 2016-2021
Table 6. United States Poliomyelitis Vaccine Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Poliomyelitis Vaccine Price (2016-2021) & (USD/Unit)
Table 8. Manufacturers Poliomyelitis Vaccine Product Type
Table 9. List of Tier 1 Poliomyelitis Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Poliomyelitis Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Poliomyelitis Vaccine ?
Table 12. Major Manufacturers of Poliomyelitis Vaccine ?
Table 13. By Type - United States Poliomyelitis Vaccine Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Poliomyelitis Vaccine Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Poliomyelitis Vaccine Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Poliomyelitis Vaccine Sales (K Units), 2016-2021
Table 17. By Type - United States Poliomyelitis Vaccine Sales (K Units), 2022-2027
Table 18. By Application - United States Poliomyelitis Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Poliomyelitis Vaccine Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Poliomyelitis Vaccine Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Poliomyelitis Vaccine Sales (K Units), 2016-2021
Table 22. By Application - United States Poliomyelitis Vaccine Sales (K Units), 2022-2027
Table 23. GSK Corporation Information
Table 24. GSK Description and Major Businesses
Table 25. GSK Poliomyelitis Vaccine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 26. GSK Poliomyelitis Vaccine Product
Table 27. GSK Recent Developments
Table 28. Sanofi-Pasteur Corporation Information
Table 29. Sanofi-Pasteur Description and Major Businesses
Table 30. Sanofi-Pasteur Poliomyelitis Vaccine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 31. Sanofi-Pasteur Poliomyelitis Vaccine Product
Table 32. Sanofi-Pasteur Recent Developments
Table 33. Merck Corporation Information
Table 34. Merck Description and Major Businesses
Table 35. Merck Poliomyelitis Vaccine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 36. Merck Poliomyelitis Vaccine Product
Table 37. Merck Recent Developments
Table 38. Crucell Corporation Information
Table 39. Crucell Description and Major Businesses
Table 40. Crucell Poliomyelitis Vaccine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 41. Crucell Poliomyelitis Vaccine Product
Table 42. Crucell Recent Developments
Table 43. China National Biotech Group Corporation Information
Table 44. China National Biotech Group Description and Major Businesses
Table 45. China National Biotech Group Poliomyelitis Vaccine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 46. China National Biotech Group Poliomyelitis Vaccine Product
Table 47. China National Biotech Group Recent Developments
Table 48. Eli Lilly Corporation Information
Table 49. Eli Lilly Description and Major Businesses
Table 50. Eli Lilly Poliomyelitis Vaccine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 51. Eli Lilly Poliomyelitis Vaccine Product
Table 52. Eli Lilly Recent Developments
Table 53. Poliomyelitis Vaccine Production Capacity (K Units) of Key Manufacturers in United States Market, 2019-2021 (K Units)
Table 54. United States Poliomyelitis Vaccine Capacity Market Share of Key Manufacturers, 2019-2021
Table 55. Poliomyelitis Vaccine Market Opportunities & Trends in United States Market
Table 56. Poliomyelitis Vaccine Market Drivers in United States Market
Table 57. Poliomyelitis Vaccine Market Restraints in United States Market
Table 58. Poliomyelitis Vaccine Raw Materials
Table 59. Poliomyelitis Vaccine Raw Materials Suppliers in United States Market
Table 60. Typical Poliomyelitis Vaccine Downstream
Table 61. Poliomyelitis Vaccine Downstream Clients in United States Market
Table 62. Poliomyelitis Vaccine Distributors and Sales Agents in United States Market
List of Figures
Figure 1. Poliomyelitis Vaccine Product Picture
Figure 2. Poliomyelitis Vaccine Segment by Type
Figure 3. Poliomyelitis Vaccine Segment by Application
Figure 4. United States Poliomyelitis Vaccine Market Overview: 2020
Figure 5. United States Poliomyelitis Vaccine Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Poliomyelitis Vaccine Revenue, 2016-2027 (US$, Mn)
Figure 7. Poliomyelitis Vaccine Sales in United States Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Poliomyelitis Vaccine Revenue in 2020
Figure 9. Poliomyelitis Vaccine ? Product Picture
Figure 10. Poliomyelitis Vaccine ? Product Picture
Figure 11. Poliomyelitis Vaccine ? Product Picture
Figure 12. Oral Poliomyelitis Vaccine Product Picture
Figure 13. By Type - United States Poliomyelitis Vaccine Sales Market Share, 2016-2027
Figure 14. By Type - United States Poliomyelitis Vaccine Revenue Market Share, 2016-2027
Figure 15. By Type - United States Poliomyelitis Vaccine Price (USD/Unit), 2016-2027
Figure 16. VAPP
Figure 17. VDPV
Figure 18. By Application - United States Poliomyelitis Vaccine Sales Market Share, 2016-2027
Figure 19. By Application - United States Poliomyelitis Vaccine Revenue Market Share, 2016-2027
Figure 20. By Application - United States Poliomyelitis Vaccine Price (USD/Unit), 2016-2027
Figure 21. GSK Poliomyelitis Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Sanofi-Pasteur Poliomyelitis Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Merck Poliomyelitis Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Crucell Poliomyelitis Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. China National Biotech Group Poliomyelitis Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Eli Lilly Poliomyelitis Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. United States Poliomyelitis Vaccine Production Capacity (K Units), 2016-2027
Figure 28. Poliomyelitis Vaccine Industry Value Chain
Figure 29. Marketing Channels

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs